
After three decades moving between agencies, consumer brands, consulting and the automotive aisle, Samantha Avivi has arrived at Bayer's global CMO seat with a durable operating idea: trust is built by listening closely, making boldly and giving teams room to grow.
Mikael Svensson is Chief Executive Officer of SaNOtize Research and Development Corp., the Vancouver-based company commercializing nitric oxide as an antimicrobial platform, most recently through its NOWONDER consumer nasal cleanser. A chemical engineer by training with more than two decades in medical device and pharmaceutical commercialization, he previously led the global launch of INOmax inhaled nitric oxide therapy and worldwide expansion work on Restylane, Naftin, Mederma and VagiVital.
Rony Sellam is the CEO of InsideTracker, a Cambridge, Massachusetts based personalized-health company that uses blood biomarkers, DNA and lifestyle data to give consumers actionable recommendations for extending healthspan. A former Deloitte consultant from France by way of Geneva and a longtime healthcare IT executive, he has run InsideTracker for over a decade and helped push the company past 100,000 members and into partnerships with Oura and Fitness SF.
Emily Stein is a microbiologist turned founder and CEO of Primal Health, the Minneapolis life-sciences company behind Daily Dental Care for people and TEEF for Life for pets. Trained at UC Berkeley and Stanford, she spent more than a decade building SMMRT (Selective Microbial Metabolism Regulation Technology), a 'carrot and stick' approach that starves harmful mouth bacteria and feeds the helpful ones instead of nuking everything. Holder of 18 patents and a five-time startup founder, Stein pivoted from humans to dogs when dentists balked, a move she says saved the company. Her stated goal: to be in every mouth at least once a day.

Hasti Nazem is the Co-CEO and Head of Product and Education at Kindra, a New York-based, science-backed women's health brand building estrogen-free solutions for menopause, vaginal health and intimate care. With roughly a decade at the intersection of life sciences, consumer brand-building and wellness, she co-leads the company alongside Afshan Dosani, grounding products in 160+ clinical studies and patent-pending peptide technology. She came to the work through a winding path: a family of physicians, a pre-med start, a detour into finance before the 2008 crash, and a return to school that led her to build wellness companies focused on sleep and, later, women's health.
Michael Pollak is a New York based serial founder who keeps spotting personal-care rituals stuck in old-fashioned settings and rebuilding them as warm, branded experiences. He co-founded Heyday, the company that pulled the facial out of the spa and grew it into a national chain, then in 2024 launched Great Many, a hair growth studio and telehealth brand in NoHo that treats thinning hair with the comfort of a lounge and the rigor of a clinic. Trained at the Cornell Hotel School, he leads with hospitality instincts and gut-first decisions.
Eric Marcotulli is the co-founder and CEO of Elysium Health, a New York consumer health company he started in 2014 to turn academic aging research into products people can actually buy. A former wrestler who became Sequoia Capital's youngest partner before he turned 30, he left venture capital after a business-school case study on cellular aging convinced him that longevity was a solvable engineering problem, not a fairy tale. He built Elysium by recruiting Nobel laureates and a roster of world-class scientists as advisors, raising more than $70 million across several rounds, and selling directly to consumers.
Dan McCormick is the co-founder and CEO of Create Wellness, the New York brand that turned creatine from a bodybuilder's powder into a daily gummy. After years inside high-growth consumer companies like Away, Parade and the Not Boring newsletter, he started Create in 2022 with his wife Sienna and pioneered the first creatine monohydrate gummy. The company has sold over 250 million gummies, reached GNC and Target shelves, and raised a $20M Series B in 2026 led by Alliance Consumer Growth.

Sienna McCormick is the co-founder and co-CEO of Create Wellness, the New York company that turned creatine - long stuck in the bodybuilder aisle - into a daily gummy. After six years at Goldman Sachs, she and her husband Dan bootstrapped the brand from their apartment in 2022, shipped the first creatine monohydrate gummy after more than twenty manufacturers said it could not be done, and have since sold north of 250 million of them. In March 2026 the company raised a $20 million Series B led by Alliance Consumer Growth, with the stated ambition of getting 100 million Americans onto daily creatine by 2030.
Bobn L is the Chief Executive Officer of GoodRx, the Santa Monica-based digital health company that has become America's most-used prescription savings platform. GoodRx tracks drug prices across 75,000+ pharmacies nationwide, delivering coupons and transparency to millions of Americans navigating the opaque world of prescription pricing. Under executive leadership, GoodRx has grown to nearly $800 million in annual revenue, gone public on Nasdaq (GDRX), and expanded into telemedicine - all in service of a single idea: that patients deserve to know what their medications actually cost.
Glen Tullman is a serial health-tech entrepreneur and CEO of Transcarent, the consumer-directed health and care platform he founded in 2021. Over three decades he turned Allscripts into the dominant electronic health records provider, founded Livongo Health and sold it to Teladoc for $18.5 billion - the largest consumer digital health deal in history - and co-founded 7wireVentures, one of the top-returning venture funds in Illinois. Now leading Transcarent's $621M acquisition of Accolade and pushing AI-powered 'WayFinding' tools into employee benefits, Tullman is also a Giving Pledge signatory who has committed most of his estimated $1 billion fortune to healthcare and education.
Zack Scott is a General Partner and Co-Head of the Healthcare Investment Team at Norwest Venture Partners, one of Silicon Valley's most active multi-stage venture capital firms. A rare combination of clinically trained physician and seasoned investor, Scott brings an MD from UT Health San Antonio and an MBA from Duke's Fuqua School of Business to a career that spans surgical residency, healthcare venture investing at Burrill & Company, co-founding Revelation Partners (a healthcare-focused secondary investment firm), and now leading healthcare deals at Norwest. His portfolio includes companies like ShiraTronics, SetPoint Medical, Cytovale, and Galvanize Therapeutics, with notable exits including Omada Health's IPO and acquisitions by Stryker, Zoll Medical, Abbott, and Olympus.
Bryan Faust, PhD is an Investment Partner on the Bio + Health team at Andreessen Horowitz (a16z), where he backs seed and Series A companies at the intersection of biology and technology. A trained biophysicist with a PhD from UCSF, he published research in Nature, Science, and Cell before pivoting to venture—studying antibody-protein interactions, GPCR signaling, and COVID-19 nanobodies along the way. At a16z he has co-led investments in Stipple Bio, Tessera Labs, Gate Bioscience, and Formation Bio, and writes widely on AI in life sciences, biotech financing, and the coming era of programmable medicine. When he's not reading pitch decks, he's surfing, roasting coffee, or hunting down the perfect tacos al pastor.
Katia Ameri is a Partner at Andreessen Horowitz (a16z) focused on the intersection of consumer and technology. An LA native of Iranian descent and Stanford graduate, she was the first investment hire at Pear VC, then founded Mirra - a skincare company that grew to 200,000+ newsletter subscribers with zero ad spend - before joining a16z in 2021. At a16z she leads consumer investments, runs the Speedrun accelerator program, and is the founder of Tech Week by a16z, a decentralized conference series in SF, LA, and NYC that drew 40,000+ attendees and 1,000+ events in New York alone.